Thousands of women battling advanced breast cancer could be denied access to crucial life-extending medication due to an ...

Women with HER2-positive breast cancer can be treated with AstraZeneca and Daiichi Sankyo's Enhertu, regardless of whether their cancer has spread to the brain, according to a new study.

PITTSBURGH — Some 264,000 women will get a breast cancer diagnosis this year, with 50% to 60% of them having a type of cancer called HER2 low. That means the tumors have low levels of the HER2 ...

Leah Hughes was 29 when she first noticed a lump in her breast — but when she told her doctor, they brushed it off as a ...

The documents show that blockbuster cancer drugs like pembrolizumab (brand Keytruda), osimertinib (brand Tagrisso), and ...

A mum who has breast cancer is one of thousands of women who could be "missing out" on life-extending drugs because of the way they are assessed by the health service, a charity has warned. Breast ...

The company is betting that the alternative cytotoxic payload in its ADC can overcome resistance in patients who relapse on Enhertu.

The German Institute for Quality and Efficiency in Health Care (IQWiG) has examined the pros and cons of biomarker-based ...

The list recommending customs duty of 5% includes 74 drugs, while another suggesting full exemption has 69 drugs. A separate ...

This year's American Society of Clinical Oncology (ASCO) meeting delivered a packed agenda of breast cancer research, with major updates for antibody-drug conjugates, HER2-positive regimens, and ...

When Lea Hughes first spotted a small lump on her breast she was reassured it was just due to 'hormones'. But two years later ...